Relative Strength Chart Protagonist Therapeutics, Inc.
Equities
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.48 USD | -1.70% |
|
+4.68% | +43.73% |
| 07-07 | Protagonist Therapeutics, Inc. - Special Call | |
| 06-17 | Citigroup Initiates Protagonist Therapeutics at Buy With $72 Price Target | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -1.70% | +4.68% | +43.73% | +56.06% | +235.63% | 3.44B |  |  | |
- Stock Market
- Equities
- PTGX Stock
- Charts Protagonist Therapeutics, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition